MacDermid, an NYSE-listed specialty chemicals maker, has brought in Merrill Lynch to advise it on a proposed $1bn (€789m) private equity-backed managment buyout.

MacDermid said today that a special committee of the board will "weigh the MBO and any other alternatives that may be available to the company."